Invivyd, Inc. (IVVD)
0.6022
+0.04
(+6.96%)
USD |
NASDAQ |
Nov 09, 14:15
Invivyd Net Income (Quarterly) : -44.39M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -44.39M |
| March 31, 2026 | -41.40M |
| December 31, 2025 | -11.07M |
| September 30, 2025 | -10.47M |
| June 30, 2025 | -14.66M |
| March 31, 2025 | -16.29M |
| December 31, 2024 | -18.44M |
| September 30, 2024 | -60.74M |
| June 30, 2024 | -47.25M |
| March 31, 2024 | -43.50M |
| December 31, 2023 | -73.65M |
| September 30, 2023 | -39.44M |
| Date | Value |
|---|---|
| June 30, 2023 | -50.23M |
| March 31, 2023 | -35.32M |
| December 31, 2022 | -44.57M |
| September 30, 2022 | -45.09M |
| June 30, 2022 | -50.99M |
| March 31, 2022 | -100.67M |
| December 31, 2021 | -83.04M |
| September 30, 2021 | -60.38M |
| June 30, 2021 | -44.67M |
| March 31, 2021 | -38.70M |
| December 31, 2020 | -17.21M |
| September 30, 2020 | -48.01M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Lineage Cell Therapeutics, Inc. | 1.544M |
| Armata Pharmaceuticals, Inc. | 74.14M |
| Voyager Therapeutics, Inc. | -24.69M |
| Black Diamond Therapeutics, Inc. | -9.905M |
| Elicio Therapeutics, Inc. | -7.979M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 14.28M |
| Total Expenses (Quarterly) | 58.68M |
| EPS Diluted (Quarterly) | -0.1385 |
| Enterprise Value | 14.26M |
| Gross Profit Margin (Quarterly) | 86.62% |
| Profit Margin (Quarterly) | -310.8% |
| Earnings Yield | -61.94% |
| Normalized Earnings Yield | -61.94 |